<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">

    <title>Outbreak.info Resource Tagger</title>

    <meta name="description" content="Organizing information for COVID-19 researchers with the help of citizen science">

    <link href="/static/css/bootstrap.min.css" rel="stylesheet">
    <link href="/static/css/style.css" rel="stylesheet">

  </head>
  <body>

    <div class="container-fluid">
	<div class="row">
		<div class="col-md-12">
			<div class="obHeaderBar">
				<h2 class="landingDescriptor-heading">
					Outbreak.info Resource Tagger
				</h2>
            </div>
            <div class="obDefinitionsBody">
				<h3>
                  Category Definitions
                </h3>
                <p>
                  These are the descriptions for each of the Topic Categories for Outbreak.info.  
                    There are 9 <b><u>broad categories</u></b>, and 24 <b><i>specific subcategories</i></b>. 
                    <p>Whenever possible, please select the most appropriate <b><i>subcategories</i></b> in lieu of the <b><u>broad category</u></b>. 
                    <p>If you find that a specific subcategory is appropriate, there is NO need to select the corresponding broad category.
                    <ul>
                    <li><b><u>Clinical</u> - Clinical presentations of COVID-19. This encompasses work related to the observation and treatment of actual patients.</b> </li>
                    <ul><li><i><b>Case Descriptions</b></i> - Descriptions of specific patient cases. e.g.- Clinical Case Report. </li>
                    <li><i><b>Risk Factors</b></i> - Risk factors associated with case presentation, severity, or mortality</li>
                    </ul>
                    <li><b><u>Diagnosis</u> - Disease assessment through symptoms, test results, and radiological features</b></li>
                    <ul>
                    <li><i><b>Symptoms</b></i> - Diagnosis based off clinical symptoms</li>
                    <li><i><b>Rapid Diagnostics</b></i> - Diagnosis based off of rapid testing procedures and generally enable point of care testing.</li>
                    <li><i><b>Antibody Detection</b></i> - Antibody-based detection. Enables determination of past history of infection by looking at an aspect of the body's immunological response to the virus.</li>
                    <li><i><b>Virus Detection</b></i> - RT-PCR detection. Enables determination of active infection by looking for the presence of viral genetic material.</li>
                    <li><i><b>Testing Prevalence</b></i> - Extent of testing</li>
                    <li><i><b>Pathology/Radiology</b></i> - Diagnosis based off pathology and/or radiology. This often involves some sort of patient sampling (e.g.- like a biopsy or dissection), and some sort of imaging technology (e.g.- microscopy, x-rays, ct scans, etc.) </li>
                    </ul>
                    <li><b><u>Forecasting</u> - Modelling and estimating the trend of COVID-19 spread</b></li>
                    <li><b><u>Mechanism</u> - Underlying cause(s) of COVID-19 infections and transmission and possible drug mechanism of action</b></li>
                    <ul>
                    <li><i><b>Virus Factors</b></i> - How virus factors influence infection and transmission. This includes viral genes and proteins.</li>
                    <li><i><b>Host Factors</b></i> - How host genetic factors influence infection and transmission. This includes variant genes and proteins in the host.</li>
                    <li><i><b>Immunological Response</b></i> - Description of immunological response upon virus exposure. </li>
                    <li><i><b>Mechanism of Infection</b></i> - Description of how the virus enters and infects human cells</li>
                    <li><i><b>Mechanism of Transmission</b></i> - Description of how the virus transmits between hosts</li>
                    </ul>
                    <li><b><u>Prevention</u> - Prevention, control, and management strategies either at the individual or societal level</b></li>
                    <ul>
                    <li><i><b>Public Health Interventions</b></i> - Descriptions of public health interventions and/or evaluations of their efficacy</li>
                    <li><i><b>Individual Prevention</b></i> - Descriptions of individual transmission prevention methods and/or their efficacy, including behavior change campaigns</li>
                    </ul>
                    <li><b><u>Transmission</u> - Characteristics and modes of COVID-19 transmissions, such as human-to-human</b></li>
                    <ul>
                    <li><i><b>Host/Intermediate Reservoirs</b></i> - Descriptions of the host source of SARS-CoV-2 and its spread through intermediate reservoirs</li>
                    <li><i><b>Viral Shedding / Persistence</b></i> - How much the virus sheds from host and how long it persists in environments</li>
                    </ul>
                    <li><b><u>Treatment</u> - Treatment strategies, therapeutic procedures, and vaccine development</b></li>
                    <ul>
                    <li><i><b>Vaccines</b></i> - Vaccine development and immune response</li>
                    <li><i><b>Pharmaceutical Treatments</b></i> - Development of new pharmaceutical treatments of COVID-19, especially small molecule development</li>
                    <li><i><b>Repurposing</b></i> - Repurposing candidates of approved drugs</li>
                    <li><i><b>Biologics</b></i> - Development of biologically based treatments of COVID-19, including the use of convalescent plasma</li>
                    <li><i><b>Medical Care</b></i> - Medical interventions or procedures to treat COVID-19 such as dialysis, ventilators, etc.</li>
                    </ul>
                    <li><b><u>Epidemiology</u> - Description of the spread of cases</b></li>
                    <ul>
                    <li><i><b>Molecular epidemiology</b></i> - Description of chains of transmission, R0, doubling time, dating outbreak in specific regions/overall based on molecular/genetic assays</li>
                    <li><i><b>Classical epidemiology</b></i> - Description of cases, chains of transmission, broader scale dynamics (R0, doubling time, duration of infectiousness,...) based on classical epidemiological methods like case counts and contact tracing</li>
                    </ul>
                    <li><b><u>Behavioral Research</u> - Mental health, behavioral, or social science research directly or indirectly related to COVID-19 such as studies on depression or social isolation, incidence of domestic violence, protests against public health directives, and more</b>.</li>
                    </ul>
			</div>
		</div>
	</div>
</div>


  </body>
</html>